Some side effects are common, some rare, while others are due to weight loss rather than the drugs themselves
& Gomes, M
Tirzepatides Phase 3 programme is four years deeper, its three FDA approvals span type 2 diabetes, chronic weight management and obstructive sleep apnoea, and its published cardiovascular outcomes trial in more than thirteen thousand patients is a fact we do not dispute 12 28
This comprehensive view reveals that the medication represents 70 to 85 percent of total costs, but the remaining 15 to 30 percent still amounts to $1,000 to $3,000 annually
Does retatrutide have worse side effects than Mounjaro
If you or a family member has experienced serious complications after taking a GLP-1 drug such as Ozempic, Wegovy, Mounjaro, or Zepbound, our Chicago product liability lawyers are here to help